January 5, [removed]Vol[removed]Nos. 51 - Nucleoside - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2001-08-06 10:02:32 HIV/AIDS Medical terms Ketones Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Post-exposure prophylaxis Nevirapine Antiretroviral drug AIDS Medicine Health Chemistry		January 5, [removed]Vol[removed]Nos. 51 &[removed]Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures — Worldwide, 1997–2000 Add to Reading List Source URL: www.cdc.gov Download Document from Source Website File Size: 171,60 KB Share Document on Facebook

	BMS_Gilead_Logo_FINAL.eps DocID: 1m38a - View Document
	New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension Nevirapine DocID: 1gvCL - View Document
	Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information DocID: 1gtrY - View Document
	ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL DocID: 1fNy0 - View Document
	1 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations DocID: 1fw0V - View Document